Spectral AI, Inc.
NASDAQ:MDAI · NASDAQ Capital Market
+$0.01 today
Vol 0.49M · Avg 1.00M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Stock Ticker Earnings Waterfall
NASDAQ:MDAI · Revenue to Net Income
Key Ratios
Analysis
$16.7M of revenue converted into -$14.3M of net income for the selected period. Gross margin is 44.6% and net margin is -79.9%, showing how much revenue survives after costs and taxes. EPS is $-0.53, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $19.6M -33.6% | $29.6M +63.8% | $18.1M -28.8% | $25.4M +66.5% | $15.2M | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $10.7M -34.2% | $16.3M +60.2% | $10.2M -30.0% | $14.5M +77.5% | $8.2M | $725.6M | $804.0M | $882.4M |
| Gross Profit | $8.9M -32.8% | $13.3M +68.5% | $7.9M -27.3% | $10.8M +53.7% | $7.1M | $8.9B | $7.6B | $6.2B |
| Gross Margin | 45.4% +0.5pp | 44.9% +1.2pp | 43.6% +0.9pp | 42.7% -3.6pp | 46.3% | 9.8% | 28.9% | 38.3% |
| Research & Development | $19.6M -33.6% | $29.6M | $0 | $0 | $0 | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $17.5M -11.7% | $19.9M -4.8% | $20.9M +54.7% | $13.5M +20.1% | $11.2M | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $17.5M -11.7% | $19.9M -4.8% | $20.9M +54.7% | $13.5M +20.1% | $11.2M | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $635.0K +8.0% | $588.0K -18.6% | $722.0K +27.1% | $568.0K +56700.0% | $1.0K | $374.2M | $1.2B | $631.8M |
| EBITDA | -$5.4M +52.8% | -$11.5M +42.9% | -$20.1M -799.1% | -$2.2M +45.2% | -$4.1M | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | -27.6% +11.3pp | -38.8% +72.6pp | -111.4% -102.6pp | -8.8% +18.0pp | -26.8% | 5.6% | 46.3% | 42.0% |
| Operating Income | -$8.6M -30.7% | -$6.6M +49.3% | -$13.0M -390.5% | -$2.6M +36.7% | -$4.2M | $12.3B | $14.0B | -$15.7B |
| Operating Margin | -43.8% -21.5pp | -22.3% +49.7pp | -71.9% -61.5pp | -10.4% +17.0pp | -27.4% | 16.6% | 24.1% | 22.0% |
| Interest Income | -$886.0K -6428.6% | $14.0K -91.9% | $172.0K +719.0% | $21.0K | $0 | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $1.5M -49.2% | $3.0M | $0 | $0 | $0 | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | $1.0M +112.3% | -$8.5M -7.7% | -$7.9M -4842.8% | -$159.0K -271.0% | $93.0K | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | -$7.6M +49.7% | -$15.0M +27.8% | -$20.8M -642.8% | -$2.8M +31.3% | -$4.1M | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | -38.5% +12.4pp | -50.9% +64.6pp | -115.4% -104.4pp | -11.1% +15.8pp | -26.8% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | $11.0K -95.9% | $271.0K +2363.6% | $11.0K -89.6% | $106.0K +208.2% | -$98.0K | $1.3B | -$1.6B | $745.2M |
| Net Income | -$7.6M +50.6% | -$15.3M +26.6% | -$20.9M -616.1% | -$2.9M +27.0% | -$4.0M | $4.9B | $4.8B | $4.7B |
| Net Margin | -38.5% +13.2pp | -51.8% +63.7pp | -115.5% -104.0pp | -11.5% +14.7pp | -26.2% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | -$0 +65.9% | -$1 +42.6% | -$1 -825.0% | -$0 +51.5% | -$0 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | -$0 +65.9% | -$1 +42.6% | -$1 -825.0% | -$0 +51.5% | -$0 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $26.5M +47.9% | $17.9M +27.3% | $14.1M -21.2% | $17.9M +0.0% | $17.9M | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $26.5M +47.9% | $17.9M +27.3% | $14.1M -21.2% | $17.9M +0.0% | $17.9M | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Karyopharm Therapeutics Inc.
NASDAQ:KPTI
$208.27M
Century Therapeutics, Inc.
NASDAQ:IPSC
$197.81M
Equillium, Inc.
NASDAQ:EQ
$107.81M
electroCore, Inc.
NASDAQ:ECOR
$67.69M
Coeptis Therapeutics, Inc.
NASDAQ:COEP
$55.98M
Telomir Pharmaceuticals, Inc. Common Stock
TELO
$46.11M
Sensus Healthcare, Inc.
SRTS
$45.19M
TELA Bio, Inc.
TELA
$35.81M
Cytosorbents Corporation
CTSO
$29.31M
IceCure Medical Ltd
ICCM
$12.61M
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does MDAI generate?
Spectral AI, Inc. (MDAI) reported $19.65M of revenue in fiscal 2025.
Is MDAI profitable?
Spectral AI, Inc. (MDAI) reported -$7,571,000.00 of net income, with a net margin of -38.5%.
Explore More
Continue the stock analysis
Jump to another research area for this company.